Adaptive Biotechnologies Corpor

Historical 13F Holders

Symbol
ADPT
CUSIP
00650F109
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 310 159 M $3.48 B
2026 Q1 304 152 M $2.11 B
2025 Q4 293 150 M $2.44 B
2025 Q3 277 146 M $2.18 B
2025 Q2 250 149 M $1.74 B
2025 Q1 232 155 M $1.15 B
2024 Q4 213 143 M $859 M
2024 Q3 194 144 M $737 M
2024 Q2 184 150 M $544 M
2024 Q1 198 144 M $462 M
2023 Q4 210 146 M $714 M
2023 Q3 199 141 M $770 M
2023 Q2 219 137 M $921 M
2023 Q1 237 134 M $1.18 B
2022 Q4 236 135 M $1.03 B
2022 Q3 237 131 M $932 M
2022 Q2 221 134 M $1.08 B
2022 Q1 233 126 M $1.74 B
2021 Q4 226 124 M $3.48 B
2021 Q3 229 118 M $4.01 B
2021 Q2 244 118 M $4.81 B
2021 Q1 264 114 M $4.60 B
2020 Q4 270 114 M $6.77 B
2020 Q3 220 111 M $5.41 B
2020 Q2 213 101 M $4.89 B
2020 Q1 156 97.1 M $2.70 B
2019 Q4 141 86.5 M $2.59 B
2019 Q3 126 82.0 M $2.52 B
2019 Q2 113 78.2 M $3.74 B
2019 Q1 1 104 k $4.25 M
2016 Q3 2 248 $10.7 k
2016 Q2 1 13.0 $672.00
2016 Q1 1 9.00 $500.00